Literature DB >> 20631862

Successful management of hemopericardium and cardiac tamponade secondary to occult malignancy and anticoagulation.

David H Hsi1, Mahesh Krishnamurthy, Gerald F Ryan, Pifu Luo, Timothy J Woodlock.   

Abstract

In patients presenting with pericarditis or pericardial effusion without known malignancy, the likelihood of finding previously undiagnosed cancer in different publications typically ranges from 4% to 7%. Cardiac tamponade due to malignant pericardial effusion is thus a rare clinical entity and often acutely life threatening. The present report describes an unusual case of large pericardial bleeding causing tamponade in the setting of fondaparinux anticoagulation, heterozygous factor V Leiden mutation and eventual discovery of meta-static adenocarcinoma.

Entities:  

Keywords:  Adenocarcinoma of unknown primary; Factor V Leiden mutation; Fondaparinux; Malignant pericardial effusion; Pericardial tamponade

Year:  2010        PMID: 20631862      PMCID: PMC2898533     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  7 in total

1.  Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.

Authors:  Richard H White; Helen K Chew; Hong Zhou; Arti Parikh-Patel; David Harris; Danielle Harvey; Theodore Wun
Journal:  Arch Intern Med       Date:  2005 Aug 8-22

Review 2.  Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.

Authors:  J D Wilkes; P Fidias; L Vaickus; R P Perez
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

3.  Neoplasms metastatic to the heart: review of 3314 consecutive autopsies.

Authors:  K P Abraham; V Reddy; P Gattuso
Journal:  Am J Cardiovasc Pathol       Date:  1990

4.  Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion.

Authors:  Heather L Gornik; Marie Gerhard-Herman; Joshua A Beckman
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

5.  Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.

Authors:  T S Tsang; J B Seward; M E Barnes; K R Bailey; L J Sinak; L H Urban; S N Hayes
Journal:  Mayo Clin Proc       Date:  2000-03       Impact factor: 7.616

6.  Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies.

Authors:  K Y Lam; P Dickens; A C Chan
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

7.  Cardiac tamponade in medical patients: a 10-year follow-up survey.

Authors:  Jean-Christophe Cornily; Pierre-Yves Pennec; Philippe Castellant; Eric Bezon; Grégoire Le Gal; Martine Gilard; Yannick Jobic; Jacques Boschat; Jean-Jacques Blanc
Journal:  Cardiology       Date:  2008-04-25       Impact factor: 1.869

  7 in total
  3 in total

1.  Spontaneous isolated pericardial tamponade associated with warfarin.

Authors:  Recep Akgedik; Zeki Yüksel Günaydın; Deniz Kızılırmak; Yusuf Emre Gürel
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 2.  Hemopericardium in the acute clinical setting: Are we ready for a tailored management approach on the basis of MDCT findings?

Authors:  Tullio Valente; Maria Pignatiello; Giacomo Sica; Giorgio Bocchini; Gaetano Rea; Salvatore Cappabianca; Mariano Scaglione
Journal:  Radiol Med       Date:  2020-11-02       Impact factor: 3.469

3.  Spontaneous Hemorrhagic Pericardial and Pleural Effusion in a Patient Receiving Apixaban.

Authors:  Michael Cinelli; Asif Uddin; Ilirjana Duka; Armaghan Soomro; Frank Tamburrino; Foad Ghavami; James Lafferty
Journal:  Cardiol Res       Date:  2019-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.